Document Detail


The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
MedLine Citation:
PMID:  20572106     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This review summarizes the development, history and use of second-trimester sonographic markers for the detection of fetal Down syndrome over three decades. Starting with the nuchal fold thickening in 1985 and culminating in the genetic sonogram in the 1990 s. The combination of second-trimester serum screening with the ultrasound markers improved the detection rate of affected fetuses but also allowed patients to decrease their risk of carrying a fetus with Down syndrome if the genetic sonogram was normal. More recently the role of the genetic sonogram and its markers have changed with the wide spread use of first-trimester screening. This prior screening ultimately decreases the prevalence of fetal Down syndrome in the second trimester to less than 85% of what it was in the first-trimester as most fetuses with Down syndrome are now identified early. Current interpretation of the second-trimester Down syndrome markers must be based on the result of the first trimester and combined screening to achieve the most accurate risk estimate of an affected fetus.
Authors:
Beryl R Benacerraf
Related Documents :
9166166 - Maternal serum screening for down syndrome in the united states: a 1995 survey.
19032666 - Combining first and second trimester markers for down syndrome screening: think twice.
21618146 - Adiposity, joint and systemic inflammation: the additional risk of having a metabolic s...
3412586 - Kearns-sayre syndrome in twins: lethal dominant mutation or acquired disease?
16441466 - Systematic review: complementary and alternative medicine in the irritable bowel syndrome.
19757336 - Late occurrence of severe hyponatremia followed by extrapontine osmotic demyelination s...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  30     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-28     Completed Date:  2010-10-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  644-52     Citation Subset:  IM    
Copyright Information:
(c) 2010 John Wiley & Sons, Ltd.
Affiliation:
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. bbsono@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Down Syndrome / ultrasonography*
Female
Fetus
Humans
Nuchal Translucency Measurement / methods*
Pregnancy
Pregnancy Trimester, Second
Ultrasonography, Prenatal / methods*
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fetal therapy: 2020 and beyond.
Next Document:  Fetal cardiac scanning today.